SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivo Bio Tech informs about postal ballot notice

05 Dec 2024 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Vivo Bio Tech has informed that it enclosed the Notice of Postal Ballot & E -Voting, together with the Explanatory Statement thereto, seeking approval of the Members for the following Special Businesses as set out in the said Notice: 1. Approval of Vivo Bio Employees Stock Option Scheme, 2024 (‘VBESOS, 2024’) and Grant of Employees Stock Options to employees of the Company thereunder. 2. Grant of Employee Stock Options to the Eligible Employees of the Subsidiary(ies) of the Company under Vivo Bio Employees Stock Option Scheme, 2024 (‘VBESOS, 2024’). 3. To Approve Grant of options to equal to or exceeding one per cent but not exceeding four per cent of the issued Capital of the Company during any one financial year to identified employees under Vivo Bio Employees Stock Option Scheme, 2024 (‘VBESOS, 2024’). The aforementioned Notice is being sent by electronic mode today December 05, 2024, to all the Members, who have registered their email addresses with the Company/Depositories/Registrar and Transfer Agents of the Company: Aarthi Consultants and whose names appear in the Register of Members / list of Beneficial Owners as on Friday, November 29, 2024. The Notice of Postal Ballot & E -Voting is also available on the website of the Company: www.vivobio.com. The remote e-voting will commence on Friday, December 06, 2024 at 9.00 am (IST) and end on Saturday, January 04, 2025 at 5.00 pm (IST), and the result thereof will be declared on or before Tuesday, January 07, 2025.

The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech Share Price

27.80 0.00 (0.00%)
24-Apr-2026 10:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.80
Dr. Reddys Lab 1310.35
Cipla 1288.70
Zydus Lifesciences 926.45
Lupin 2310.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×